(Q35693105)

9 August 2017

title

Serum metabolomics analysis reveals changes in signaling lipids in breast cancer patients (English)

1 reference

9 August 2017

1 reference

Min Cui

1

1 reference

9 August 2017

Qiaolian Wang

series ordinal

2

1 reference

9 August 2017

Guang Chen

series ordinal

3

1 reference

9 August 2017

publication date

14 July 2015

1 reference

Biomedical Chromatography

9 August 2017

published in

1 reference

9 August 2017

volume

30

1 reference

9 August 2017

issue

1

1 reference

9 August 2017

page(s)

42-47

1 reference

Early detection of recurrent breast cancer using metabolite profiling

9 August 2017

cites work

1 reference

Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy

21 January 2018

1 reference

MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status

21 January 2018

1 reference

Practical approach for the identification and isomer elucidation of biomarkers detected in a metabonomic study for the discovery of individuals at risk for diabetes by integrating the chromatographic and mass spectrometric information

21 January 2018

1 reference

Lysophospholipids and their receptors in the central nervous system

21 January 2018

1 reference

Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind

21 January 2018

1 reference

Comparison of Serum Lipid Profiles between Normal Controls and Breast Cancer Patients

21 January 2018

1 reference

Analysis of metabolomic data using support vector machines

21 January 2018

1 reference

Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis

21 January 2018

1 reference

Understanding 'Global' Systems Biology: Metabonomics and the Continuum of Metabolism

21 January 2018

1 reference

Biologically active sphingolipids in cancer pathogenesis and treatment

21 January 2018

1 reference

Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor

21 January 2018

1 reference

Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

Action and Signaling of Lysophosphatidylethanolamine in MDA-MB-231 Breast Cancer Cells

21 January 2018

1 reference

Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance

21 January 2018

1 reference

The human serum metabolome

21 January 2018

1 reference

Mass spectrometry-based quantitative metabolomics revealed a distinct lipid profile in breast cancer patients.

21 January 2018

1 reference

Diverse functions of ceramide in cancer cell death and proliferation

21 January 2018

1 reference

Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters

21 January 2018

1 reference

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

21 January 2018

1 reference

Metabolite profiles and the risk of developing diabetes

21 January 2018

1 reference

Lysophospholipids activate ovarian and breast cancer cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BMC.3556

1 reference

9 August 2017

1 reference